Stockscreener 앱 받기
234.31
2.19%
-5.25
시간 외 거래:
234.31
전일 마감가:
$239.56
열려 있는:
$241.84
하루 거래량:
966.61K
Relative Volume:
0.73
시가총액:
$32.67B
수익:
$2.12B
순이익/손실:
$-309.19M
주가수익비율:
-102.58
EPS:
-2.2841
순현금흐름:
$93.57M
1주 성능:
+2.39%
1개월 성능:
-0.52%
6개월 성능:
+44.86%
1년 성능:
+32.67%
1일 변동 폭
$232.36
$241.90
1주일 범위
$227.69
$256.36
52주 변동 폭
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
NTRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
234.31 | 33.41B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | Citigroup | Buy |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-27 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 재개 | Wells Fargo | Equal Weight |
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Is Natera Inc. stock attractive after correctionWatch List & Consistent Income Trade Ideas - ulpravda.ru
Natera (NTRA) announces publication of findings from randomized, phase III CALGB (Alliance)/SWOG 80702 study - MSN
Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research® - GlobeNewswire Inc.
How Natera ctDNA Partnership Around STELLAR-316 At Exelixis (EXEL) Has Changed Its Investment Story - Yahoo Finance
Will Natera Inc. stock outperform tech sector in 2025Insider Buying & Real-Time Stock Entry Alerts - ulpravda.ru
Can Natera Inc. stock sustain market leadership2025 AllTime Highs & Risk Controlled Stock Pick Alerts - ulpravda.ru
Is Natera Inc. stock attractive for growth ETFs2025 Top Gainers & Free High Accuracy Swing Entry Alerts - ulpravda.ru
NTRANatera Inc Latest Stock News & Market Updates - Stock Titan
Will Natera Inc. stock gain from strong economyQuarterly Portfolio Report & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Can Natera Inc. stock weather global recessionJuly 2025 Momentum & Reliable Entry Point Alerts - ulpravda.ru
Can Natera Inc. stock beat analyst upgradesJuly 2025 Opening Moves & Real-Time Chart Pattern Alerts - ulpravda.ru
EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study - Finviz
Assessing Natera (NTRA) Valuation After Positive ALTAIR Trial Data And Expanded Fetal Focus Test Launch - simplywall.st
Medical stock hovers near buy point after 46% gain - MSN
Why Natera’s Stock Is Sliding Despite Bullish Outlook - TipRanks
Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera - CNBC
Exelixis and Natera stocks rise on colorectal cancer trial collaboration By Investing.com - Investing.com South Africa
Exelixis and Natera stocks rise on colorectal cancer trial collaboration - Investing.com
Exelixis, Natera to Collaborate on Phase 3 Colorectal Cancer Trial - MarketScreener
Exelixis and Natera to collaborate on Stellar-316, a phase 3 pivotal trial of zanzalintinib - MarketScreener
Insiders At Natera Sold US$47m In Stock, Alluding To Potential Weakness - Yahoo Finance
Citigroup Initiates Buy Rating on Natera (NTRA) with $300 Price Target | NTRA Stock News - GuruFocus
Exelixis and Natera to collaborate on MRD-guided cancer trial By Investing.com - Investing.com Australia
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer - Yahoo Finance
Natera: Leading MRD Position, Expanding Margins, and Premium Valuation Support Buy Rating and $300 Target - TipRanks
Natera Inc: President Moshkevich sells $675k in stock By Investing.com - Investing.com South Africa
Natera Inc: President Moshkevich sells $675k in stock - Investing.com India
Natera Inc stock hits all-time high at 247.0 USD - Investing.com
Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI - BioSpace
Expanded Fetal Test and Stronger ALTAIR Signal Could Be A Game Changer For Natera (NTRA) - simplywall.st
NTRA Gains Momentum as Guggenheim Raises Price Target to $270 | - GuruFocus
Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology - Yahoo Finance
Is Natera (NASDAQ:NTRA) A Risky Investment? - 富途牛牛
Natera (NASDAQ:NTRA) Upgraded at Zacks Research - MarketBeat
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Calamos Advisors LLC Has $930,000 Holdings in Natera, Inc. $NTRA - MarketBeat
Responsive Playbooks and the NTRA Inflection - Stock Traders Daily
Ninety One UK Ltd Sells 218,812 Shares of Natera, Inc. $NTRA - MarketBeat
Allspring Global Investments Holdings LLC Sells 47,131 Shares of Natera, Inc. $NTRA - MarketBeat
Miami man arrested in nearly $1 million theft from tech company he worked for: Cops - NBC 6 South Florida
Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study - Finviz
Miami man accused of stealing nearly $1 million from 2 South Florida businesses - WPLG Local 10
Natera, Inc. (NASDAQ:NTRA) Short Interest Update - MarketBeat
Natera CFO sells shares worth $7.76 million - MSN
Medical Stock Hovers Near Buy Point After 46% Gain - Investor's Business Daily
Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Immunome (IMNM) - The Globe and Mail
Cwm LLC Increases Stake in Natera, Inc. $NTRA - MarketBeat
Vontobel Holding Ltd. Increases Stock Position in Natera, Inc. $NTRA - MarketBeat
Natera is Transforming Patient Care Using AI - Amazon Web Services (AWS)
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Natera Inc 주식 (NTRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Jan 02 '26 |
Sale |
228.95 |
2,951 |
675,621 |
123,499 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Jan 02 '26 |
Sale |
229.08 |
3,848 |
881,482 |
136,568 |
1.36%
0.32%
자본화:
|
볼륨(24시간):